| |
MISSION STATEMENT
NorthEast Bioanalytical Laboratories is committed to providing high quality services to the pharmaceutical, biotechnical and animal health industries.
Our mission is to develop partnerships with our clients.
• Assist clients in overcoming obstacles by developing effective and
efficient drug development processes and study designs.
• Provide and array of services allowing NEBA to assume
responsibility for most if not all aspects of a project, allowing our
clients to focus on other priorities.
• Maintain open and prompt communication with our client at each phase of their studies.
• Reinforce our clients' trust and confidence in our services by
continually providing personalized, high quality and timely service.
• Maintain high ethical and professional standards in all facets of a study.
• Treat each customer with respect and ensure complete customer satisfaction.
Our success is measured in client satisfaction.
Tom Stephen, Ph.D., CGI Pharmaceuticals, Inc.
"I
have worked with a number of companies (large and small) over the years
and NEBA is by far the most responsive. In an industry where a
vast majority of businesses establish practices that remain rigid, NEBA
works with the client to provide the most efficient and cost effective
approach to getting the job done. The integrity of the scientific
staff is refreshing as well as their willingness to provide scientific
input and high quality data. They truly go the extra mile to make
the collaborations successful and I will continue to enjoy very
productive interactions with them in the future."
David Goldman, Ph.D., Pharmaceuticals International, Inc.
"My experience with NEBA has been a very good one. We received
all the results and reports in desired format and without any problems.
Our experience with NEBA personnel were highly professional and
cordial in nature. They have provided us with high quality work
that has been timely and well presented. They have provided
valuable insight with pharmacokinetics and analysis of the data
(especially with the preclinical studies). I plan to continue
using their services in the future and would highly recommend them to
prospective clients."
Bernhard Beckermann, Ph.D., Bayer Schering AG, Germany
More than 20 studies at the time of this testimonial, from 2003 to 2006
"The studies ranged from method validation and stability studies,
cross-validation of other external labs, support for Investigator
Sponsored Studies, Clinical Phase I to Phase IV studies (including
pivotal BE studies). The last major study was a pivotal
bioequivalence study, where samples from a cross-over study with about
100 volunteers were to be analyzed within a very short time frame.
This study - and all other studies - were done according to a
very high quality and reporting standard and with a high
responsiveness. We have audited the Lab in 2004 by our BHC GLP
QAU and in 2006 by a BHC GLP trained bioanalytical expert, in both
cases without major findings."
|
